What is Hodgkin lymphoma?
Hodgkin lymphoma is a type of cancer that causes cells in the lymphatic system to abnormally reproduce, eventually making the body less able to fight infection. It is the most common cancer in people ages 15 to 19 and also one of the most treatable.
Hodgkin lymphoma usually begins in the lymph nodes of one part of a child's body, usually the head, neck, or chest and then tends to spread from one part of the lymphatic system to the next. In advanced stages, the disease can spread to the lungs, liver, bones, bone marrow, or other organs.
How we care for Hodgkin lymphoma
Children and young adults with Hodgkin lymphoma are treated at Dana-Farber/Boston Children's Cancer and Blood Disorders Center — a joint partnership between Dana-Farber Cancer Institute and Boston Children's Hospital — through our Lymphoma Program.
Find in-depth information on Hodgkin lymphoma on the Dana-Farber Cancer Institute website, including answers to:
- How is Hodgkin lymphoma diagnosed?
- What is the best treatment for Hodgkin lymphoma?
- What is the latest research on Hodgkin lymphoma?
- What is the long-term outlook for children with Hodgkin lymphoma?
Hodgkin Lymphoma | Programs & Services
Programs
Hematologic Malignancy Center
Program
The Dana-Farber/Boston Children’s Hematologic Malignancy Center treats children with hematologic malignancies, including leukemia and lymphoma.
Hematopoietic (Stem) Cell Transplant Program
Program
The Hematopoietic (Stem) Cell Transplant Program at Dana-Farber/Boston Children's Cancer and Blood Disorders Center is one of the largest and most experienced pediatric stem cell transplant programs in the world.
Learn more about Hematopoietic (Stem) Cell Transplant Program
Lymphoma Program
Program
The Dana-Farber/Boston Children’s Lymphoma Program is one of the leading programs of its kind.
Centers
Cancer and Blood Disorders Center
Center
The Dana-Farber/Boston Children's Cancer and Blood Disorders Center is an integrated pediatric hematology and oncology program through Dana-Farber Cancer Institute and Boston Children’s Hospital.
